Concepedia

A Treatment of Corticosteroid-Dependent Lepromatous Patients in Persistent Erythema Nodosum Leprosum - A Clinical Evaluation of G. 30320 (B663)

Florian Imkamp

Leprosy Review · 1968 · 25 citations · 2 references

DOIFull text

Open access

Concepts

Abstract

Attention to the anti-inflammatory effect of B663 was first drawn by Browne " ' . In 2 patients receiving 600 mgm. B663 daily, Williams et al. ' observed that the drug apparently controlled the signs of erythema nodosum leprosum (ENL).

References

2

Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.

John H. S. Pettit, R. J. W. Rees, D.S. Ridley · PubMed · 1967 · 16 citations

, , +8

The treatment of erythema nodosum leprosum with B.663. A controlled study.

John H. S. Pettit · PubMed · 1967 · 15 citations

, , +10